Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma

INTRODUCTION: The failure of chemotherapy in osteosarcoma results in drug resistance and acute side effects in the body. METHODS: In this study, we have prepared a novel folate receptor-targeted doxorubicin (DOX) and edelfosine (EDL)-loaded lipid–polymer hybrid nanoparticle (DE-FPLN) to enhance the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Onco Targets Ther
Главные авторы: Yang, Ping, Zhang, Lian, Wang, Tian, Liu, Qi, Wang, Jing, Wang, Yaling, Tu, Zhiquan, Lin, Feng
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434523/
https://ncbi.nlm.nih.gov/pubmed/32884291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S259428
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы